APA (7th ed.) Citation

F, M., A, V. G., J, N., & J, M. (2005). Highly active antiretroviral therapy: Cardiovascular risk needs to be assessed before starting treatment. BMJ: British Medical Journal (International Edition), 330(7504), 1341. https://doi.org/10.1136/bmj.330.7504.1341

Chicago Style (17th ed.) Citation

F, Moerman, Van Gompel A, Nimmegeers J, and Moerman J. "Highly Active Antiretroviral Therapy: Cardiovascular Risk Needs to Be Assessed Before Starting Treatment." BMJ: British Medical Journal (International Edition) 330, no. 7504 (2005): 1341. https://doi.org/10.1136/bmj.330.7504.1341.

MLA (9th ed.) Citation

F, Moerman, et al. "Highly Active Antiretroviral Therapy: Cardiovascular Risk Needs to Be Assessed Before Starting Treatment." BMJ: British Medical Journal (International Edition), vol. 330, no. 7504, 2005, p. 1341, https://doi.org/10.1136/bmj.330.7504.1341.